Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fidelity Biosciences
MedTech
Amphora raises $36M to trial overactive bladder treatment
The series B round equips Amphora to take its minimally invasive, cystoscopic device into the last step of clinical development next year.
Nick Paul Taylor
Jul 21, 2017 6:47am
Novartis-backed GenSight gets cash for gene therapy launch
Jun 23, 2017 9:30am
Amazon's Bezos, Mayo Clinic back Unity in $116M Series B to slow diseases of aging
Oct 27, 2016 2:03pm
Fidelity backs rare disease startup with $48M to get pivotal data
Oct 3, 2016 9:43am
